PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
12-Feb-2021 Innovation Sprint boosts the AI portfolio of Healthentia for clinical research and eHealth with new R&D projects Innovation Sprint
12-Feb-2021 Global Medical Simulation Market is Anticipated to Reach $3,251 million by 2025 at a CAGR of 14.0% | Apex Market Research Apex Market Research
11-Feb-2021 First Patient Enrolled in SELUTION SLR™ SUCCESS PTA Study MedAlliance
10-Feb-2021 Two Exclusive Interviews Release with Pfizer and Novo Nordisk ahead of Pharmaceutical Microbiology East Coast Virtual Conference  SMi Group
10-Feb-2021 Cell And Gene Market Therapeutic Developments and Research 2020 to 2026 Ameliorate Digital Consultancy PVT. LTD.
10-Feb-2021 International Conference on Arthroplasty and Orthopedic Surgery Scientex Conferences
09-Feb-2021 Polish expansion for UK and Ireland-based CRO adds more capability and deepens alignment with academia Transpharmation
09-Feb-2021 Global Brain Monitoring Market is Booming to Reach $6,595 Million Value Mark by 2025 | Apex Market Research Apex Market Research
08-Feb-2021 Biologic Excipients Market: Opportunity Analysis Report By Component, Top Players & End User, 2020-2028 Meridian Market Consultants
08-Feb-2021 Europital board forewarns that clinical deficits to slow biotech development in 2021 Europital
08-Feb-2021 PharmiWeb.Jobs Welcomes Biophorum PharmiWeb.Jobs
05-Feb-2021 Global Healthcare Analytical Testing Services Market Study (2021): Industry trends, Evaluation of Market status, Projected growth by 2030 Marketresearch.biz
03-Feb-2021 Three Key Start-ups Join SMi’s 2nd Annual AI in Drug Discovery Virtual Conference  SMi Group
02-Feb-2021 NEW HOPE FOR WOMEN WITH SUSPECTED ENDOMETRIAL CANCER AS INNOVATIVE URINE TEST RULES OUT DISEASE IN UP TO 99% OF CASES Arquer Diagnostics
02-Feb-2021 Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study of Birtamimab in Mayo Stage IV Patients with AL Amyloidosis under SPA Agreement with FDA Prothena
02-Feb-2021 Tiziana Reports Positive Data from the Clinical Study of Nasal Administration with Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, in COVID-19 Patients in Brazil Tiziana
02-Feb-2021 GCSA Intrinsic to UK PLC Clinical Trial Offer GCSA
01-Feb-2021 PharmiWeb.Jobs Welcomes ZigZag Associates PharmiWeb.Jobs
29-Jan-2021 Toxys, Leiden University and Leiden University Medical Center Announce Licensing of ToxProfiler Technology for Animal-Free Chemical Safety Testing Toxys
29-Jan-2021 Epilepsy Therapeutic Market Therapeutic Development and Comprehensive Insights by 2026 Ameliorate Digital Consultancy PVT. LTD.